Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$75M |
| 2 |
Chevron
CVX
|
+$59.9M |
| 3 |
GE HealthCare
GEHC
|
+$57.5M |
| 4 |
Applovin
APP
|
+$54.7M |
| 5 |
OKLO
Oklo
OKLO
|
+$52.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xcel Energy
XEL
|
+$137M |
| 2 |
Meta Platforms (Facebook)
META
|
+$61.8M |
| 3 |
Becton Dickinson
BDX
|
+$59.9M |
| 4 |
CRWV
CoreWeave
CRWV
|
+$57.1M |
| 5 |
Apple
AAPL
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.73% |
| 2 | Financials | 9.81% |
| 3 | Utilities | 8.63% |
| 4 | Technology | 7.6% |
| 5 | Industrials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
1176
Safehold
SAFE
$1.1B
| $446K | ﹤0.01% |
28,676
-12,327
| -30% | -$191K |
|
1177
Marcus & Millichap
MMI
$1.23B
| $442K | ﹤0.01% |
+14,404
| New | +$437K |
|
1178
Dyne Therapeutics
DYN
$4.85B
| $440K | ﹤0.01% |
46,270
-72,599
| -61% | -$799K |
|
1179
Ooma
OOMA
$584M
| $440K | ﹤0.01% |
34,138
+5,858
| +21% | +$74.5K |
|
1180
Bank First Corp
BFC
$1.71B
| $437K | ﹤0.01% |
3,714
-183
| -5% | -$20.4K |
|
|
CSGS
1181
DELISTED
CSG Systems International
CSGS
| $437K | ﹤0.01% |
+6,692
| New | +$417K |
|
1182
Sabra Healthcare REIT
SBRA
$5.23B
| $435K | ﹤0.01% |
23,615
-254,651
| -92% | -$4.52M |
|
|
BFS
1183
Saul Centers
BFS
$844M
| $430K | ﹤0.01% |
12,587
+617
| +5% | +$20.8K |
|
1184
Citi Trends
CTRN
$619M
| $425K | ﹤0.01% |
+12,716
| New | +$324K |
|
|
ATXS
1185
DELISTED
Astria Therapeutics
ATXS
| $424K | ﹤0.01% |
79,040
+42,134
| +114% | +$204K |
|
1186
Chesapeake Utilities
CPK
$3.26B
| $423K | ﹤0.01% |
3,517
-27,261
| -89% | -$3.43M |
|
1187
Kimbell Royalty Partners
KRP
$1.56B
| $423K | ﹤0.01% |
30,321
-254,063
| -89% | -$3.33M |
|
1188
Frontline
FRO
$9.81B
| $420K | ﹤0.01% |
+25,610
| New | +$434K |
|
1189
Entegris
ENTG
$21.1B
| $419K | ﹤0.01% |
5,192
-16,106
| -76% | -$1.22M |
|
1190
McEwen Inc
MUX
$1.29B
| $419K | ﹤0.01% |
43,560
-5,977
| -12% | -$48.7K |
|
1191
Backblaze
BLZE
$963M
| $417K | ﹤0.01% |
+75,854
| New | +$386K |
|
1192
TAT Technologies
TATT
$485M
| $414K | ﹤0.01% |
+13,560
| New | +$390K |
|
1193
Ethan Allen Interiors
ETD
$592M
| $413K | ﹤0.01% |
14,821
-4,292
| -22% | -$116K |
|
|
ONT
1194
Onterris Inc
ONT
$538M
| $410K | ﹤0.01% |
18,721
-135,036
| -88% | -$2.42M |
|
|
SHOE
1195
Shoe Station Group
SHOE
$424M
| $410K | ﹤0.01% |
21,900
-159,016
| -88% | -$3.02M |
|
1196
NerdWallet
NRDS
$648M
| $408K | ﹤0.01% |
+37,160
| New | +$373K |
|
1197
Rocket Pharmaceuticals
RCKT
$388M
| $404K | ﹤0.01% |
165,037
-35,647
| -18% | -$181K |
|
1198
Vermilion Energy
VET
$1.92B
| $402K | ﹤0.01% |
55,183
-23,117
| -30% | -$158K |
|
1199
Lemonade
LMND
$4.17B
| $401K | ﹤0.01% |
9,142
+1,023
| +13% | +$34.1K |
|
|
SEMR
1200
DELISTED
Semrush
SEMR
| $401K | ﹤0.01% |
44,289
-82,253
| -65% | -$796K |
|
Similar funds
Michael Gelband's Q2 2025 Portfolio in Review
As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.
On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.
- Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
- Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
- Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
- Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
- Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
- Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
- Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.